{
  "docId": "019de074-7bfd-70c0-985e-370853614892",
  "docSlug": "be9cd2ecd1a9b4702566620e9f2aa170",
  "documentTitle": "Bionomics | Results Presentation Deck | 27 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 27,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "before_after",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The study uses a CCK-4-induced panic attack model to demonstrate Proof of Mechanism (PoM).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-7bfd-70c0-985e-370853614892/6",
  "deckHref": "/decks/019de074-7bfd-70c0-985e-370853614892",
  "deckJsonHref": "/decks/019de074-7bfd-70c0-985e-370853614892.json",
  "deckAnchorHref": "/decks/019de074-7bfd-70c0-985e-370853614892#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.54,
        "x": 0.42,
        "y": 0.18
      },
      "kind": "chart",
      "text": "BNC210 demonstrated reduction in panic symptoms as measured with the Panic Symptom Scale",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9290a8aa-6d2c-4fc1-b01c-91885449e350",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.37,
        "x": 0.04,
        "y": 0.45
      },
      "kind": "list",
      "text": "Subjects assessed after a single dose of BNC210 as they would be in an acute SAD trial setting\nProof of Mechanism (PoM) in demonstrating anxiolytic activity",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b676ff6-7468-4856-9325-411e8fa0d838",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.37,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Phase 1b placebo-controlled study evaluating BNC210 in acute anxiety in 15 healthy volunteers who experienced a CCK-4-induced panic attack",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b3c9896-bd7e-4c0b-b0a2-3df9825b53d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.08,
        "y": 0.88
      },
      "kind": "source-note",
      "text": "CCK-4 = Cholecystokinin Tetrapeptide (a peptide that induces anxiety and panic symptoms)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49ddae04-3971-4e60-b61b-ded20d2ea05d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Proof of Mechanism: BNC210 Significantly Reduces Anxiety and Panic Symptoms",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7fda4326-f68e-4f79-9baf-99cd31644485",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Before-After-Bridge",
      "slug": "before-after-bridge",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "03d95c49-5bf9-431e-92b2-ae72e2b042e7",
      "evidence": "Proof of Mechanism (PoM) in demonstrating anxiolytic activity, chart/bar-grouped: BNC210 demonstrated reduction in panic symptoms as measured with the Panic Symptom Scale",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "before-after-framing",
      "slug": null,
      "matchId": "95acdaaa-4c1e-4248-b71b-67e7b082f1ec",
      "evidence": "Compares placebo vs BNC210 results to demonstrate efficacy.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 9,
      "from": 5,
      "beatId": "a91f66d9-76dd-4ada-991d-a8d5ac9d7e1b",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The document highlights the challenges of current treatments and the impact of anxiety disorders on patients.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 5,
      "name": "Before After",
      "slug": "21-before-after",
      "bestFor": "Product demos, process improvements, ROI justification",
      "matchId": "c2bcb376-37fc-4ae2-8d27-0ff27bc7cd15",
      "evidence": "The document presents before-after comparisons of BNC210's effects on α7 receptors and anxiety symptoms.",
      "position": 0,
      "objective": "To demonstrate BNC210's ability to modulate α7 receptors and reduce anxiety symptoms",
      "structure": "The Old Way (Pain) -> The Moment of Change -> The New Way (Glory) -> The Measurable Delta",
      "confidence": 0.8,
      "description": "Show the dramatic contrast between the old way and the new way through side-by-side comparison"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}